trusted seller
Denuril Denosumab 60 Mg Injection Denuril Denosumab 60 Mg Injection Denuril Denosumab 60 Mg Injection
Denuril Denosumab 60 Mg Injection
Denuril Denosumab 60 Mg Injection Denuril Denosumab 60 Mg Injection

Denuril Denosumab 60 Mg Injection

6500 INR/Pack

Product Details:

  • Dosage Form Solution for injection
  • Salt Composition Denosumab
  • Origin of Medicine Biotechnological/biologic
  • Indication Treatment of osteoporosis, bone loss associated with prostate/breast cancer treatment, prevention of skeletal-related events in patients with bone metastases
  • Pacakaging (Quantity Per Box) 1 unit per box
  • Drug Type Biological/Monoclonal antibody
  • Ingredients Denosumab
  • Click to View more
X

Denuril Denosumab 60 Mg Injection Price And Quantity

  • 6500 INR/Pack
  • 1 Pack
  • Subcutaneous injection
  • 24 months from the date of manufacture
  • Prescription
  • 60 mg/mL
  • Denuril
  • Reliance Life Sciences Pvt Ltd
  • Clear, colorless to pale yellow solution
  • Yes
  • Hypersensitivity to denosumab, hypocalcemia
  • Musculoskeletal pain, hypercholesterolemia, urinary tract infections, hypocalcemia

Denuril Denosumab 60 Mg Injection Product Specifications

  • 1 unit per box
  • 1 prefilled syringe
  • 60 mg per prefilled syringe
  • Store in a refrigerator at 2C8C. Do not freeze.
  • Administer subcutaneously once every 6 months or as directed by a physician
  • Denosumab
  • Osteoporosis, bone loss due to hormone ablation, multiple myeloma, or cancer metastases to bone
  • Treatment of osteoporosis, bone loss associated with prostate/breast cancer treatment, prevention of skeletal-related events in patients with bone metastases
  • Inhibits osteoclast activity, reduces bone resorption, increases bone mass and strength
  • Injection
  • Adults
  • Biological/Monoclonal antibody
  • Biotechnological/biologic
  • Solution for injection
  • Denosumab
  • Subcutaneous injection
  • 24 months from the date of manufacture
  • Prescription
  • 60 mg/mL
  • Denuril
  • Reliance Life Sciences Pvt Ltd
  • Clear, colorless to pale yellow solution
  • Yes
  • Hypersensitivity to denosumab, hypocalcemia
  • Musculoskeletal pain, hypercholesterolemia, urinary tract infections, hypocalcemia

Product Description

Product introduction

Denuril Injection is a medicine used in the treatment of osteoporosis in postmenopausal women and in men at increased risk of fractures. It makes the bones strong and reduce the risk of fractures.

Denuril Injection is given by a healthcare professional and should not be self-administered. You should use it regularly and at the same time each day to get maximum benefit from it. Continue using it as recommended by your doctor and complete the dose even if you feel better. To make it more effective, take adequate amount of calcium and vitamin D supplements while on treatment with this medicine.

Some common side effects of this medicine include headache, pain in extremity, musculoskeletal pain, nerve pain, constipation, and rash. Talk to your doctor if any of these side effects does not go away with time or get worse. Your doctor may help with ways to reduce or prevent these symptoms.

To make sure the medicine is safe for you, before taking it, let your doctor know of all the other medicines you are taking. It is important for pregnant and breastfeeding mothers to ask the advice of their doctors before using this medicine.


Uses of Denuril Injection


Side effects of Denuril Injection

Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if youre worried about them



Advanced Osteoporosis Management

Denuril Denosumab is a cutting-edge monoclonal antibody formulated for adults facing osteoporosis and bone complications from cancer treatments. Its unique mechanism directly targets bone resorption, helping to boost bone mass and minimize fracture risk. Administered as a convenient, subcutaneous injection twice a year, Denuril simplifies long-term bone health maintenance and supports better outcomes in high-risk patients.


Safe, Preservative-Free Solution

Denuril is carefully formulated without preservatives, ensuring suitability for a wide range of patients, including those requiring sensitive management. The solution remains stable for up to 24 months, provided it is stored in refrigeration. Its clear appearance and controlled dosage in a prefilled syringe offers patients and clinicians peace of mind with each administration.

FAQ's of Denuril Denosumab 60 Mg Injection:


Q: How is Denuril Denosumab 60 mg Injection administered?

A: Denuril is administered by subcutaneous injection, typically into the upper arm, thigh, or abdomen. The standard dose is 60 mg every six months or as directed by your physician.

Q: What conditions does Denuril Denosumab treat?

A: Denuril is recommended for adults to treat osteoporosis, bone loss resulting from hormone ablation in breast or prostate cancer treatment, multiple myeloma, and to prevent skeletal-related complications in patients with bone metastases.

Q: When should I take Denuril Denosumab Injection?

A: Denuril is usually administered once every six months. Your healthcare provider will determine the optimal dosing schedule based on your specific medical needs.

Q: Where should Denuril Denosumab Injection be stored?

A: Store Denuril in its original packaging in a refrigerator at 2C-8C. Do not freeze or expose it to direct sunlight, and keep it out of reach of children.

Q: What are the potential benefits of Denuril Denosumab therapy?

A: Denuril helps increase bone density, reduce the risk of fractures, and lower the likelihood of skeletal-related events in cancer patients with bone involvement, thereby enhancing quality of life.

Q: What are the common side effects of Denuril Denosumab?

A: Common side effects include musculoskeletal pain, higher cholesterol levels, urinary tract infections, and hypocalcemia. Promptly consult your doctor if you experience symptoms of low calcium (e.g., muscle cramps or tingling).

Q: Who should not use Denuril Denosumab Injection?

A: Denuril should not be used by individuals with known hypersensitivity to denosumab or those with low blood calcium levels (hypocalcemia). It is essential to discuss your medical history with your doctor before starting treatment.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

Other Products in 'Rheumatoid Arthritis' category



Back to top